Stay updated with breaking news from Ucross Symposium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mural by Eliza Naranjo Morse, at the Ucross Art Gallery Field Guide Show Ucross is honored to announce that they are partnering with the Denver Art Museum to present the Ucross Symposium: Curating Native American Art, an interdisciplinary gathering of museum professionals, students, and community
Presented at Charing Cross, 10-Year Clinical Data from Global ENGAGE OUS Registry Support Endurant Stent Graft System’s AAA Market-Leading Position Worldwide
Medtronic (NYSE:MDT) today announced positive results from its 10-year post-market registry for the Endurant stent graft.
The IN.PACT AV Access study’s three-year data further demonstrates the ability for the IN.PACT AV DCB to extend time to reinterventions from the index procedure by maintaining AV access site patency, therefore maximizing a patient's uninterrupted access to lifesaving dialysis care.
Share this article Share this article IN.PACT AV Access Trial 24 Month Results Presented as a Podium First at Charing Cross Symposium DUBLIN and LONDON, April 20, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the safety and effectiveness results through 24 months for the IN.PACT AV Access clinical study. The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness throug...